Lifecome Biochemistry Co Ltd (002868) - Cash Flow Conversion Efficiency

Latest as of December 2025: -1.734x

Based on the latest financial reports, Lifecome Biochemistry Co Ltd (002868) has a cash flow conversion efficiency ratio of -1.734x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-112.57 Million ≈ $-16.47 Million USD) by net assets (CN¥64.93 Million ≈ $9.50 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 002868 stock market capitalisation for the company's overall valuation and market capitalisation.

Lifecome Biochemistry Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Lifecome Biochemistry Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Lifecome Biochemistry Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Lifecome Biochemistry Co Ltd ranked by their cash flow conversion efficiency. Explore Lifecome Biochemistry Co Ltd earnings quality ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
HangZhou Radical Energy Saving Technology Co Ltd SHE:300652	0.065x
Dexus Industria REIT AU:DXI	0.022x
Changzhou Almaden Co Ltd SHE:002623	-0.017x
IDI S.C.A. PA:IDIP	-0.008x
Cerus Corporation NASDAQ:CERS	-0.045x
Sygnity SA WAR:SGN	0.065x
Zhejiang Liming Intelligent Manufacturing Co Ltd SHG:603048	0.038x
SandRidge Energy Inc NYSE:SD	0.038x

Annual Cash Flow Conversion Efficiency for Lifecome Biochemistry Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Lifecome Biochemistry Co Ltd from 2012 to 2025. View Lifecome Biochemistry Co Ltd (002868) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥64.93 Million ≈ $9.50 Million	CN¥-25.08 Million ≈ $-3.67 Million	-0.386x	+93.30%
2024-12-31	CN¥-24.54 Million ≈ $-3.59 Million	CN¥141.41 Million ≈ $20.69 Million	-5.763x	-1177.91%
2023-12-31	CN¥414.11 Million ≈ $60.60 Million	CN¥-186.76 Million ≈ $-27.33 Million	-0.451x	-2959.86%
2022-12-31	CN¥599.30 Million ≈ $87.70 Million	CN¥-8.83 Million ≈ $-1.29 Million	-0.015x	-130.26%
2021-12-31	CN¥722.02 Million ≈ $105.65 Million	CN¥35.17 Million ≈ $5.15 Million	0.049x	-58.66%
2020-12-31	CN¥769.94 Million ≈ $112.67 Million	CN¥90.72 Million ≈ $13.28 Million	0.118x	+23.81%
2019-12-31	CN¥778.50 Million ≈ $113.92 Million	CN¥74.09 Million ≈ $10.84 Million	0.095x	-15.82%
2018-12-31	CN¥740.37 Million ≈ $108.34 Million	CN¥83.70 Million ≈ $12.25 Million	0.113x	-18.17%
2017-12-31	CN¥695.68 Million ≈ $101.80 Million	CN¥96.11 Million ≈ $14.06 Million	0.138x	-72.32%
2016-12-31	CN¥271.34 Million ≈ $39.71 Million	CN¥135.41 Million ≈ $19.81 Million	0.499x	-6.18%
2015-12-31	CN¥238.98 Million ≈ $34.97 Million	CN¥127.11 Million ≈ $18.60 Million	0.532x	+61.76%
2014-12-31	CN¥190.87 Million ≈ $27.93 Million	CN¥62.76 Million ≈ $9.18 Million	0.329x	-28.29%
2013-12-31	CN¥169.42 Million ≈ $24.79 Million	CN¥77.68 Million ≈ $11.37 Million	0.458x	+17.76%
2012-12-31	CN¥156.45 Million ≈ $22.89 Million	CN¥60.92 Million ≈ $8.91 Million	0.389x	--

About Lifecome Biochemistry Co Ltd

SHE:002868 China Biotechnology

Market Cap

$523.07 Million

CN¥3.57 Billion CNY

Market Cap Rank

#12116 Global

#3514 in China

Share Price

CN¥23.00

Change (1 day)

+0.79%

52-Week Range

CN¥21.33 - CN¥46.40

All Time High

CN¥61.57